About Purigen Biosystems
Purigen Biosystems is a company based in Pleasanton (United States) founded in 2012 was acquired by Bionano Genomics in November 2022.. Purigen Biosystems has raised $88.32 million across 7 funding rounds from investors including Agilent, HHS and Cota Capital. The company has 24 employees as of December 31, 2022. Purigen Biosystems operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Pleasanton, United States
- Employees 24 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Purigen Biosystems
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$88.32 M (USD)
in 7 rounds
-
Latest Funding Round
$34.44 M (USD), Series C
Apr 02, 2021
-
Investors
Agilent
& 6 more
-
Employee Count
24
as on Dec 31, 2022
-
Acquired by
Bionano Genomics
(Nov 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Purigen Biosystems
Purigen Biosystems has successfully raised a total of $88.32M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $34.44 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $34.4M
-
First Round
First Round
(10 Apr 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series C - Purigen Biosystems | Valuation |
investors |
|
| Jun, 2019 | Amount | Series B - Purigen Biosystems | Valuation | Agilent | |
| Jun, 2018 | Amount | Series A - Purigen Biosystems | Valuation | 5AM Ventures , Roche |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Purigen Biosystems
Purigen Biosystems has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, HHS and Cota Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic venture capital investments are focused on US sectors.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Corporate-backed venture capital firm focused on the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Purigen Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Purigen Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Purigen Biosystems Comparisons
Competitors of Purigen Biosystems
Purigen Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
DNA sequencing platform for human genome analysis is developed.
|
|
| domain | founded_year | HQ Location |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| domain | founded_year | HQ Location |
Provider of genome analysis solutions to researchers and clinicians
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Purigen Biosystems
Frequently Asked Questions about Purigen Biosystems
When was Purigen Biosystems founded?
Purigen Biosystems was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Purigen Biosystems located?
Purigen Biosystems is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Is Purigen Biosystems a funded company?
Purigen Biosystems is a funded company, having raised a total of $88.32M across 7 funding rounds to date. The company's 1st funding round was a Series A of $26.45M, raised on Apr 10, 2013.
How many employees does Purigen Biosystems have?
As of Dec 31, 2022, the latest employee count at Purigen Biosystems is 24.
What does Purigen Biosystems do?
Purigen Biosystems was founded in 2012 in Pleasanton, United States, within the biotechnology sector. Operations center on a platform utilizing isotachophoresis technology, originally developed in a Stanford University laboratory. Automated benchtop instrumentation and microfluidic chips are employed to purify and quantitate nucleic acids from diverse sources, including cancer samples. Purified DNA or RNA supports downstream applications such as next-generation sequencing, PCR, and genomic testing.
Who are the top competitors of Purigen Biosystems?
Who are Purigen Biosystems's investors?
Purigen Biosystems has 7 investors. Key investors include Agilent, HHS, Cota Capital, 5AM Ventures, and Roche.